2018
DOI: 10.1037/hea0000683
|View full text |Cite
|
Sign up to set email alerts
|

Behavioral impact of return of genetic test results for complex disease: Systematic review and meta-analysis.

Abstract: Objective. Advances in genome-wide association studies have made possible the return of genetic risk results for complex diseases. Two concerns about these results are: a) negative psychological consequences; and b) viewing probabilistic results as deterministic, leading to misinterpretation and inappropriate decisions. The present study evaluates these concerns through a meta-analytic review of existing literature. Methods. Seventeen genetic testing studies of complex disease, including 1,171 participants a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

5
35
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 50 publications
(41 citation statements)
references
References 47 publications
5
35
0
Order By: Relevance
“…Additionally, integrated models of PRS together with other lifestyle and clinical factors have enabled clinicians to more accurately quantify the risk of heart attack for patients; consequently, they have more effectively targeted the reduction of LDL cholesterol and by extension heart attack by prescribing statins to patients at the greatest overall risk of cardiovascular disease [5][6][7][8][9] . Promisingly, return of genetic risk of complex disease to at-risk patients does not induce significant self-reported negative behavior or psychological function, and some potentially positive behavioral changes have been detected 10 . While we share enthusiasm about the potential of PRS to improve health outcomes through their eventual routine implementation as clinical biomarkers, we consider the consistent observation that they are currently of far greater predictive value in individuals of recent European descent than in others to be the major ethical and scientific challenge surrounding clinical translation and, at present, the most critical limitation to genetics in precision medicine.…”
mentioning
confidence: 99%
“…Additionally, integrated models of PRS together with other lifestyle and clinical factors have enabled clinicians to more accurately quantify the risk of heart attack for patients; consequently, they have more effectively targeted the reduction of LDL cholesterol and by extension heart attack by prescribing statins to patients at the greatest overall risk of cardiovascular disease [5][6][7][8][9] . Promisingly, return of genetic risk of complex disease to at-risk patients does not induce significant self-reported negative behavior or psychological function, and some potentially positive behavioral changes have been detected 10 . While we share enthusiasm about the potential of PRS to improve health outcomes through their eventual routine implementation as clinical biomarkers, we consider the consistent observation that they are currently of far greater predictive value in individuals of recent European descent than in others to be the major ethical and scientific challenge surrounding clinical translation and, at present, the most critical limitation to genetics in precision medicine.…”
mentioning
confidence: 99%
“…Harnessing a global effort to expand genetic studies in both sample size and the scope of phenotypes, with the additional notion of the importance of population diversity 5 , PRS is expected to identify individuals with inborn health risks in clinics. While early detection and appropriate health communication should contribute to the improvement of health care 33 , the inherited genetic risks of disease onset cannot be modified.…”
Section: Discussionmentioning
confidence: 99%
“…To date, evidence about the benefits of predictive genetic testing for preventive behaviors for cancer and other diseases has been mixed. While some evidence indicates positive effects, 14 other studies have not demonstrated a benefit of genetic testing on health-promoting behaviors, 15 such as smoking cessation and physical activity. The only experimental study of the impact of genetic test reporting on risk-reduction behaviors for familial melanoma provided some initial evidence of benefit -those in a test-reporting condition (for CDKN2A or the less-penetrant MC1R) reported more recent skin self-examinations compared to those in a usual-care care condition, who received a mailed sun protection pamphlet.…”
Section: Introductionmentioning
confidence: 99%